ONC · ISSUER CIK 1651308
BeOne Medicines Ltd.
Between Jul 31, 2026 and Oct 28, 2026, 6 BeOne Medicines Ltd. insiders reported $0.00 of open-market purchases and $124.3M of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 7 of 10 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$124.3MInsider selling
−$124.3MNet open-market
Oct 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202617:08 | Oct 13, 2026 | ONC | Director, Chair, Scientific Advisory Brd | S · Sell10b5-1 | $350.99 | −31,027 | 0 | -100% | −$10.9M | ||
| Oct 15, 202617:08 | Oct 13, 2026 | ONC | Director, Chair, Scientific Advisory Brd | M · Exercise10b5-1 | $36.90 | +31,027 | 31,027 | New | $1.1M | ||
| Oct 2, 202616:53 | Sep 30, 2026 | ONC | SVP, General Counsel | S · Sell10b5-1 | $375.00 | −1,115 | 0 | -100% | −$418K | ||
| Sep 30, 202617:11 | Sep 28, 2026 | ONC | Director, Chair, Scientific Advisory Brd | S · Sell10b5-1 | $364.79 | −31,028 | 0 | -100% | −$11.3M | ||
| Sep 30, 202617:11 | Sep 28, 2026 | ONC | Director, Chair, Scientific Advisory Brd | M · Exercise10b5-1 | $36.90 | +31,028 | 31,028 | New | $1.1M | ||
| Sep 10, 202616:49 | Sep 8, 2026 | ONC | Director, Chair, Scientific Advisory Brd | S · Sell10b5-1 | $349.10 | −38,287 | 0 | -100% | −$13.4M | ||
| Sep 10, 202616:49 | Sep 8, 2026 | ONC | Director, Chair, Scientific Advisory Brd | M · Exercise10b5-1 | $36.90 | +31,027 | 31,027 | New | $1.1M | ||
| Sep 3, 202617:17 | Sep 1, 2026 | ONC | Principal Accounting Officer | S · Sell | $355.86 | −132 | 0 | -100% | −$47K | ||
| Aug 27, 202617:12 | Aug 25, 2026 | ONC | President and COO | S · Sell10b5-1 | $380.00 | −280 | 0 | -100% | −$106K | ||
| Aug 13, 202620:54 | Aug 11, 2026 | ONC | SVP, General Counsel | S · Sell10b5-1 | $360.00 | −2,666 | 0 | -100% | −$960K | ||
| Aug 13, 202620:54 | Aug 11, 2026 | ONC | SVP, General Counsel | M · Exercise10b5-1 | $191.37 | +2,666 | 2,666 | New | $510K | ||
| Aug 12, 202617:53 | Aug 12, 2026from Aug 10, 2026 | ONC | Chief Executive Officer, Director | S · Sell10b5-1 | $359.12 | −240,810 | 0 | -100% | −$86.5M | ||
| Aug 5, 202617:15 | Aug 3, 2026 | ONC | Chief Financial Officer | S · Sell | $312.72 | −1,157 | 0 | -100% | −$362K | ||
| Aug 3, 202617:18 | Jul 30, 2026 | ONC | SVP, General Counsel | S · Sell | $323.69 | −1,044 | 0 | -100% | −$338K |